Gene therapy with lipid nanoparticles for Fabry disease: Leveraging E-selectin for targeted delivery to endothelial cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gene therapy with lipid nanoparticles for Fabry disease: Leveraging E-selectin for targeted delivery to endothelial cells

Published:2024-09 Issue: Volume:99 Page:105954
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Rodríguez-Castejón Julen^ORCID,Plantinga Josée A.,Beraza-Millor Marina^ORCID,Solinís María Ángeles^ORCID,Rodríguez-Gascón Alicia^ORCID,del Pozo-Rodríguez Ana^ORCID,Kamps Jan A.A.M.

Publisher

Elsevier BV

Reference52 articles.

1. Fabry disease: where are we now?;Turkmen;Int. Urol. Nephrol.,2020

2. Anderson-Fabry disease: a multiorgan disease;Tuttolomondo;Curr. Pharmaceut. Des.,2013

3. Natural history of fabry renal disease: influence of α-galactosidase a activity and genetic mutations on clinical course;Branton;Medicine (Baltim.),2002

4. Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey;Linhart;Eur. Heart J.,2007

5. Anderson-Fabry disease: from endothelial dysfunction to emerging therapies;Stamerra;Adv. Pharmacol. Pharm. Sci.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP